US RSV Vaccine Restrictions Defy Evidence of 81% Hospitalisation Drop
New US policy restricts RSV vaccines to high-risk infants despite studies showing shots cut hospitalisations by 81%. Experts warn the move could reverse progress against the dangerous virus.